Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)

CompletedOBSERVATIONAL
Enrollment

827

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

August 30, 2024

Conditions
Lung AdenocarcinomaSurgical Procedure, UnspecifiedPathology
Interventions
PROCEDURE

Surgical resection

Surgical resection of lung adenocarcinoma. Wedge resection, segmentectomy or lobectomy will be performed according to each patients' condition.

Trial Locations (1)

200032

Fudan University Cancer Center, Shanghai

All Listed Sponsors
collaborator

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

collaborator

Tongji Hospital, Wuhan, Hubei Province, China

UNKNOWN

collaborator

Sixth People's Hospital, Shanghai, China

UNKNOWN

collaborator

Ningbo Clinical Pathological Diagnostic Center, Ningbo, Zhejiang Province, China

UNKNOWN

collaborator

Dongfang Hospital Affiliated to Tongji University, Shanghai, China

UNKNOWN

collaborator

Minhang Hospital Affiliated to Fudan University, Shanghai, China

UNKNOWN

collaborator

People's Hospital of Jiangdu, Yangzhou, Jiangsu Province, China

UNKNOWN

collaborator

Liaocheng People's Second Hospital, Liaocheng, Shandong Province, China

UNKNOWN

collaborator

Guanxian People's Hospital, Liaocheng, Shandong Province, China

UNKNOWN

collaborator

Zhoupu Hospital, Pudong New Area, Shanghai, China

OTHER

lead

Fudan University

OTHER

NCT05794698 - Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014) | Biotech Hunter | Biotech Hunter